The incidence of atopic dermatitis, a chronic inflammatory skin disease, in both adults and children is still high. An altered microbiota appears to be among the risk factors.
The symptomatology is sometimes disabling and it is accompanied by a high incidence (60% of the population with at least one experience): for this, we are looking for new targeted, effective, potentially safer and more tolerated intervention strategies.
Scientific research is investigating the possible role of the intestinal microbiota in the modulation of related symptoms together with the use of
innovative ingredients based on Lactobacilli probiotics to treat skin diseases; when orally administered, probiotics-based ingredients show a significantly improved condition of subjects with atopic dermatitis, decreasing the severity and symptoms both from a clinical and self-perception point of view. This approach could lay the foundations for new approaches combined with positive effects in the short and long term.